Cargando…
Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission
INTRODUCTION: Intensive care unit (ICU) admission is required for approximately 25% of patients affected with coronavirus disease-19 (COVID-19) and imposes a high economic burden on patients in resource-limited settings. METHOD: We conducted a retrospective direct medical care cost analysis of COVID...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645812/ https://www.ncbi.nlm.nih.gov/pubmed/34916743 http://dx.doi.org/10.5005/jp-journals-10071-23991 |
_version_ | 1784610387239370752 |
---|---|
author | Reddy, Kamini N Shah, Jignesh Iyer, Shivakumar Chowdhury, Monidipa Yerrapalem, Naveen Pasalkar, Neeraja Jedge, Prashant P |
author_facet | Reddy, Kamini N Shah, Jignesh Iyer, Shivakumar Chowdhury, Monidipa Yerrapalem, Naveen Pasalkar, Neeraja Jedge, Prashant P |
author_sort | Reddy, Kamini N |
collection | PubMed |
description | INTRODUCTION: Intensive care unit (ICU) admission is required for approximately 25% of patients affected with coronavirus disease-19 (COVID-19) and imposes a high economic burden on patients in resource-limited settings. METHOD: We conducted a retrospective direct medical care cost analysis of COVID-19 patients requiring ICU admission after obtaining the Institutional Ethics Committee approval. Data were obtained from the records of patients admitted to the COVID-19 ICU of a tertiary care trust teaching hospital from June 2020 to December 2020. Direct costs were analyzed and correlated with various demographic variables and clinical outcomes. RESULTS: A total of 176 patients were included (males—76%). The median direct medical cost for a median stay of 13 days was INR 202248.5 ($ 2742.91). Hospital drugs and disposables accounted for 20% of the total cost followed by bed charges (19%), equipment charges (17%), biosafety protective gear (15.5%), pathological and radiological tests (15%), clinical management (7.6%), and biomedical waste management (1.6%). Government schemes accounted for 79% of medical claims followed by directly paying patients (12.5%) and private insurance (8.5%). The cost was significantly higher in patients with diabetes mellitus and sepsis and in those requiring mechanical ventilation (MV) (p <0.05). Shorter lead time to hospital admission and lesser length of hospital stay were associated with significant lower direct cost. CONCLUSION: Direct medical care cost is substantial for COVID-19 patients requiring ICU admission. This cost is significantly associated with increased ICU and hospital stay, longer lead time to admission, diabetes mellitus, sepsis, and those who need high-flow nasal cannula (HFNC), noninvasive ventilation (NIV), and MV. HOW TO CITE THIS ARTICLE: Reddy KN, Shah J, Iyer S, Chowdhury M, Yerrapalem N, Pasalkar N, et al. Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission. Indian J Crit Care Med 2021;25(10):1120–1125. |
format | Online Article Text |
id | pubmed-8645812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-86458122021-12-15 Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission Reddy, Kamini N Shah, Jignesh Iyer, Shivakumar Chowdhury, Monidipa Yerrapalem, Naveen Pasalkar, Neeraja Jedge, Prashant P Indian J Crit Care Med Original Article INTRODUCTION: Intensive care unit (ICU) admission is required for approximately 25% of patients affected with coronavirus disease-19 (COVID-19) and imposes a high economic burden on patients in resource-limited settings. METHOD: We conducted a retrospective direct medical care cost analysis of COVID-19 patients requiring ICU admission after obtaining the Institutional Ethics Committee approval. Data were obtained from the records of patients admitted to the COVID-19 ICU of a tertiary care trust teaching hospital from June 2020 to December 2020. Direct costs were analyzed and correlated with various demographic variables and clinical outcomes. RESULTS: A total of 176 patients were included (males—76%). The median direct medical cost for a median stay of 13 days was INR 202248.5 ($ 2742.91). Hospital drugs and disposables accounted for 20% of the total cost followed by bed charges (19%), equipment charges (17%), biosafety protective gear (15.5%), pathological and radiological tests (15%), clinical management (7.6%), and biomedical waste management (1.6%). Government schemes accounted for 79% of medical claims followed by directly paying patients (12.5%) and private insurance (8.5%). The cost was significantly higher in patients with diabetes mellitus and sepsis and in those requiring mechanical ventilation (MV) (p <0.05). Shorter lead time to hospital admission and lesser length of hospital stay were associated with significant lower direct cost. CONCLUSION: Direct medical care cost is substantial for COVID-19 patients requiring ICU admission. This cost is significantly associated with increased ICU and hospital stay, longer lead time to admission, diabetes mellitus, sepsis, and those who need high-flow nasal cannula (HFNC), noninvasive ventilation (NIV), and MV. HOW TO CITE THIS ARTICLE: Reddy KN, Shah J, Iyer S, Chowdhury M, Yerrapalem N, Pasalkar N, et al. Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission. Indian J Crit Care Med 2021;25(10):1120–1125. Jaypee Brothers Medical Publishers 2021-10 /pmc/articles/PMC8645812/ /pubmed/34916743 http://dx.doi.org/10.5005/jp-journals-10071-23991 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Article Reddy, Kamini N Shah, Jignesh Iyer, Shivakumar Chowdhury, Monidipa Yerrapalem, Naveen Pasalkar, Neeraja Jedge, Prashant P Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission |
title | Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission |
title_full | Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission |
title_fullStr | Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission |
title_full_unstemmed | Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission |
title_short | Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission |
title_sort | direct medical cost analysis of indian covid-19 patients requiring critical care admission |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645812/ https://www.ncbi.nlm.nih.gov/pubmed/34916743 http://dx.doi.org/10.5005/jp-journals-10071-23991 |
work_keys_str_mv | AT reddykaminin directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission AT shahjignesh directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission AT iyershivakumar directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission AT chowdhurymonidipa directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission AT yerrapalemnaveen directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission AT pasalkarneeraja directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission AT jedgeprashantp directmedicalcostanalysisofindiancovid19patientsrequiringcriticalcareadmission |